NICE ASSESSMENT OUTCOMES | 2023 | (2/N) | UK HEALTHCARE NEWS | IPHARMACENTER
Camzyos (mavacamten) has been recommended as a viable option for treating symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in...
top of page
Germany healthcare news | 2023 | Bundestag reforms | Digital Health | iPharmaCenter
The Cabinet has given the green light to two key laws: the "Digital Act" (Digital-Gesetz - DigiG) and the "Health Data Utilization Act"...
NICE ASSESSMENT OUTCOMES | 2023 (1/N) United Kingdom | Healthcare | Pharma | News | iPharmaCenter
Yescarta has been recommended for adults with diffuse large B-cell lymphoma (DLBCL) after one treatment and is currently indicated as the...
HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter
Find the latest healthcare and pharmaceutical news of France | HAS assessment outcomes and drug approvals in France of 2023
NICE ASSESSMENT OUTCOMES | 2022 United Kingdom | Healthcare | Pharma | News | Blogs | iPharm
December 15, 2022 SOBI's Doptelet was recommended for treating refractory primary chronic immune thrombocytopenia. NICE recommended using...
NHS England News | NHS to offer Tagrisso for lung cancer patients
NHS to offer Tagrisso for lung cancer patients NHS England announced that it would roll out Tagrisso (osimertinib) for lung cancer...
bottom of page